Evidence map›Paper›PMID 35647419›Full record

ArticleJournal of vascular surgery cases and innovative techniques2022

Portalvein reconstruction with a cadaveric descending thoracic aortic homograft.

Ann C Gaffey, Jason Zhang, Major K Lee, Robert Roses, Benjamin M Jackson, Jon G Quatromoni

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of vascular surgery cases and innovative techniques, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ann C GaffeyDivision of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Diego, La Jolla, CA.
Jason ZhangDivision of Vascular Surgery and Endovascular Therapy, University of Pennsylvania Health System, Philadelphia, PA.
Major K LeeDivision of Gastrointestinal Surgery, University of Pennsylvania Health System, Philadelphia, PA.
Robert RosesDivision of Endocrine and Oncologic Surgery, University of Pennsylvania Health System, Philadelphia, PA.
Benjamin M JacksonDivision of Endocrine and Oncologic Surgery, University of Pennsylvania Health System, Philadelphia, PA.
Jon G QuatromoniDepartment of Vascular Surgery, Cleveland Clinic, Cleveland, OH.
University of Pennsylvania Health System · USCleveland Clinic · USUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improvements in chemoradiotherapy have rendered complex pancreatic cancers involving the portal vein (PV) amenable to resection. PV reconstruction (PVR) is an essential component. Various conduits have been proposed; however, the optimal choice remains unknown. Fourteen patients underwent PVR with a cadaveric descending thoracic aortic homograft from 2014 to 2020. The primary diagnosis was pancreatic cancer. The splenic vein was ligated in seven patients (50%). The 30-day and 3-, 12-, and 24-month primary patency rates were 100%, 86%, 76%, and 76%, respectively. We found a cadaveric descending thoracic aortic homograft is an excellent conduit for PVR, given the optimal size, rapidly availability, favorable risk profile, and absence of harvest site complications.

Indexed as

HomograftOncologic reconstructionPortal vein reconstruction

Identifiers

PMID35647419
PMCPMC9133702
OpenAlexW4226153642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.